Coronavirus: Vaccination

Department for Business, Energy and Industrial Strategy written question – answered on 4th February 2021.

Alert me about debates like this

Photo of Mark Harper Mark Harper Conservative, Forest of Dean

To ask the Secretary of State for Business, Energy and Industrial Strategy, if he will proactively plan for and stock the Novavax and Johnson and Johnson vaccines, pending the completion of their clinical trials and UK approval process.

Photo of Nadhim Zahawi Nadhim Zahawi Parliamentary Under-Secretary (Department for Business, Energy and Industrial Strategy), The Parliamentary Under-Secretary for Health and Social Care

The UK Government has secured early access to 407 million vaccines doses through agreements with seven separate vaccine developers. This includes agreements with Novavax for 60 million doses and Janssen for 30 million doses.

Subject to regulatory approval by the Medicines and Healthcare products Regulatory Agency (MHRA), which will review and analyse the relevant data to see if the vaccines meet their strict standards of safety and effectiveness, these vaccines are expected to be delivered in the second half of this year.

The Government is committed to ensuring access to vaccines as soon as is safely possible, which is why it is considering all options to help achieve this objective.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.